Nonalcoholic steatohepatitis

Wojciech Deroń; Katarzyna Krawczyk; Ewa Małecka-Panas

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2008
vol. 3

Send email

Copy url:

abstract:

Nonalcoholic steatohepatitis

Wojciech Deroń

,

Katarzyna Krawczyk

,

Ewa Małecka-Panas

Przegląd Gastroenterologiczny 2008; 3 (2): 118–124

Online publish date: 2008/04/18

View full text Get citation

Nonalcoholic steatohepatitis (NASH) is a disease that is strictly related to nonalcoholic fatty liver disease. In the biopsy we could find both fatty hepatocyte factors and their inflammation features. Frequent occurrence of sickness is correlated with overweight, obesity, diabetes as well as hyperlipidaemia. The only way to get a certain diagnosis is to make a biopsy. In the study there are presented results of research on drugs that may help hinder progression, stop or reduce fatty liver features.

keywords:

Nonalcoholic steatohepatitis

Wojciech Deroń , Katarzyna Krawczyk , Ewa Małecka-Panas

nonalcoholic steatohepatitis, NASH, liver biopsy

Wojciech Deroń

,

Katarzyna Krawczyk

,

Ewa Małecka-Panas